SHOULD ANTENATAL SCREENING FOR HEPATITIS C VIRUS SHOULD BE MADE PART OF ROUTINE CARE IN THE UK?
|
|
- Ira Boyd
- 5 years ago
- Views:
Transcription
1 The West London Medical Journal 2010 Vol 2 1 pp 1-11 SHOULD ANTENATAL SCREENING FOR HEPATITIS C VIRUS SHOULD BE MADE PART OF ROUTINE CARE IN THE UK? Krupa Pitroda Screening has the potential to save lives or improve quality of life through early diagnosis of serious conditions.(1) The plethora of benefits of screening is highlighted through the success of various screening programmes already instituted worldwide. However, despite these advantages, it is neither practical nor sensible to screen for all known conditions; there are certain criteria that need to be satisfied before a screening programme can be implemented. This article will focus on the issue of antenatal screening for hepatitis C virus (HCV) infection. I will begin by defining screening and the criteria for a successful screening programme. I will then proceed to focus on how these criteria can be applied to HCV, by discussing the course of infection from mother to child and, simultaneously, analysing the implications for screening. In order to complete the article, I will summarise the current situation in the UK and discuss areas of ongoing research. The National Screening Committee define screening as the systematic application of a test or enquiry, to identify individuals at sufficient risk to benefit from further investigation or direct preventative action, amongst persons who have not sought medical attention on account of symptoms of that disorder. The infectious diseases in pregnancy screening programme aims to reduce the risk of in-utero or intrapartum mother-to-infant transmission of four conditions, which could be carried (asymptomatically) by the mother, namely: Hepatitis B, HIV, Rubella and Syphilis. The transmission of these conditions from mother to child can have serious consequences for the fetus and antenatal screening aims to reduce the likelihood of these occurring. Screening is carried out early in gestation, where a blood sample is taken from the mother, having obtained consent, and tested for markers of infection of the four mentioned conditions. Upon analysing the test results, appropriate measures can be taken and guidance provided. For various reasons, reasons, there are some infectious diseases for which antenatal screening is currently not recommended, including cytomegalovirus, toxoplasmosis, and HCV. There are certain criteria which need to be satisfied before the establishment of a successful screening programme, namely that: 1. The condition being screened for is an important health problem; 2. The natural history of the condition is understood; 1
2 THE WEST LONDON MEDICAL JOURNAL , 1 3. There is treatment or intervention of proven effectiveness available; 4. Early detection and treatment has benefit over later detection and treatment; and 5. The screening test is safe, acceptable, has justifiable costs, and the risk of both physical and psychological harm is less than the chance of benefit. It is important to remember that screening is targeting apparently healthy people and therefore has numerous ethical implications. Therefore, in order to evaluate the usefulness of routine antenatal screening in the UK, it is important to analyse the mentioned criteria, with specific focus on HCV and the situation in the UK. It is not appropriate to introduce routine antenatal screening for HCV infection in the UK at this time, in the light of the evidence currently available.(2) A critical analysis of the screening criteria and the data available regarding HCV infection may shed light onto the rationale behind this decision. HCV infection is a major public health problem.(3) Hepatitis encompasses inflammation of the liver, caused by immunological abnormalities, toxic substances or viral infection. Five major viruses are implicated: hepatitis A, B, C, D and E. The HCV is a small enveloped single-stranded RNA virus of the Flaviviridae family. It has been classified into 6 major genotypes, with over 50 different subtypes. It is a blood-borne virus and transmission therefore generally occurs through infected blood, via intravenous drug abuse and other percutaneous exposures, such as tattooing and body piercing. The acquisition of the virus through contaminated blood transfusions has been virtually eliminated through the routine screening of donor blood, introduced in It is important to note that sometimes risk factors for HCV infection can not be identified in those infected and this may have implications for other modes of acquisition of the virus, including horizontal and sexual transmission. The presence of HCV infection in adults can be diagnosed by the identification of anti-hcv antibodies in the serum by enzyme immunoassay. Detection of HCV RNA by Polymerase Chain Reaction (PCR) is the gold standard of identification of presence of infection; however, this technique is mainly used to monitor its course, by measuring viraemia. Recently, a test measuring HCV core antigen has been devised, which can also qualify and quantify infection, and studies are being carried out to monitor its efficacy. Following the introduction of vaccination against Hepatitis B, HCV has become the most important cause of chronic hepatitis and end-stage liver disease worldwide.(4) In adults, the infection can be acute or progress to chronicity. The acute stage is generally asymptomatic or mildly symptomatic, however, 85% of individuals go on to develop chronic infection, of which 20% will develop liver cirrhosis and 1-4% will progress to hepatocellular carcinoma. 2
3 SHOULD ANTENATAL SCREENING FOR HEPATITIS C VIRUS SHOULD BE MADE PART OF ROUTINE CARE IN THE UK? The World Health Organisation estimates that 3% of the world s population is chronically infected with HCV, although the prevalence is much higher (70-90%) in certain groups, such as intravenous drug users (IVDUs).(5) HCV is also more common in those infected with HIV, due to the shared routes of acquisition of these infections. In the UK, however, HCV/HIV co-infection is rare. The overall prevalence amongst pregnant women in the UK is estimated to be below 1%, although this is based on limited data. A study carried out in inner London, where there is a high prevalence of IVDUs, reported the antenatal prevalence to be 0.8%.(6) However, it is not clear whether this value can be extrapolated to the general antenatal population, due to the wide variation in prevalence according to the characteristics of the population studied. Regarding paediatric HCV infection, following the introduction of routine blood screening prior to transfusion, vertical transmission from mother-tochild is the most common cause. The risk of transmission is approximately 5%, ranging from 3-7%,(7) and there are various factors that affect transmission. A higher maternal viral load is associated with an increased risk of vertical transmission; however, a threshold has not been identified above which transmission always occurs, or below which transmission never occurs. It is important to note that transmission is almost always restricted to those who are HCV RNA positive (i.e. are viraemic) and rarely occurs in those who are HCV RNA negative (but anti-hcv antibody positive). Transmission is more commonly associated with HCV genotypes 1b and 3a. HIV co-infection with HCV is associated with a 15% risk of transmission.(3) This increased rate is thought to be due to the higher maternal viral load, as a result of maternal immunosuppression. This persistent viraemia is also thought to be responsible for the increased rate of transmission seen in IVDUs. The effect of mode of delivery, other obstetric procedures and breastfeeding is uncertain. Table 1 summarises the potential risk factors for transmission. Risk Factor Maternal HCV viraemia/ maternal viral load Findings Very low risk in from nonviraemic women. In viraemic women, a high viral load increases risk. Strength of the evidence (strong> sufficient> insufficient) Sufficient Potentially modifiable? Guidelines 3
4 THE WEST LONDON MEDICAL JOURNAL , 1 Risk Factor Maternal HIV coinfection Obstetric procedures Mode delivery of Rupture of membranes Prematurity Findings 2-3 fold increased risk in co-infected women. Amniocentesis is unlikely to increase the risk. Use of forceps during vaginal delivery is associated with a 3-fold increased risk. evidence for a protective effect of Caesarean section in women infected only with HCV. An increased duration of rupture of membranes may increase the risk of transmission. evidence to say that gestational age is significantly associated with HCV transmission. Strength of the evidence (strong> sufficient> insufficient) Strong Potentially modifiable? Guidelines Insufficient Yes Prudent to avoid these procedures whenever possible Sufficient Yes Current evidence does not support the recommendation of elective Caesarean for HCV infection without HIV. Insufficient Sufficient 4
5 SHOULD ANTENATAL SCREENING FOR HEPATITIS C VIRUS SHOULD BE MADE PART OF ROUTINE CARE IN THE UK? Risk Factor Gender Infant feeding Findings Girls are twice as likely to be infected as boys. evidence of increased risk of transmission through breastfeeding in women infected solely with HCV. Strength of the evidence (strong> sufficient> insufficient) Sufficient Potentially modifiable? Guidelines Sufficient Yes The avoidance of breastfeeding is NOT recommended in HCV infected women. Table 1: The risk factors potentially associated with vertical transmission of HCV from mother-to-infant. Guidelines based on the findings are also shown, as well as the strength of the evidence available.(7) Regarding the timing of transmission, it has been estimated that between a ⅓ to ½ of infected children acquired the infection in utero. Intrapartum transmission is not as common and postpartum transmission is rare. This has various implications for intervention, discussed later. In contrast to adult HCV infection, early paediatric HCV infection can not be diagnosed based solely on the presence of anti-hcv antibodies in the serum; this is due to the transplacental passage of antibodies during pregnancy, so all infants born to HCV positive mothers will be seropositive at birth. These antibodies are generally cleared by months age in uninfected children. Earlier diagnosis therefore requires detection of viraemia via PCR monitoring of HCV RNA. Following studies of sensitivity (the ability of a test to pick up true positives) and specificity (the ability of a test to pick up true negatives) of this technique, the ideal schedule of follow-up of children born to HCV positive mothers was suggested (Figure 2). Overall, it has been estimated that, in the UK, 69 vertically acquired paediatric HCV infections occur each year, giving a UK antenatal prevalence of 0.16%.(3) Following the vertical acquisition of the virus, the natural history of paediatric HCV infection is not completely understood. It has been shown that there are few clinical consequences of HCV infection in the short and medium term, where the infection is relatively benign. At birth, children are asymptomatic and they develop few clinical signs in the first 5-10 years of 5
6 THE WEST LONDON MEDICAL JOURNAL , 1 life. Mild hepatomegaly is seen is some children, and there may be variations in the alanine aminotranferase (ALT) levels. It is important to note that ALT Figure 2: The recommended follow-up schedule for early diagnosis of infection in infants born to HCV positive mothers. te that testing is delayed till 2 months age due to the low sensitivity of the technique at birth.(7) elevation does not correlate well with histological severity. The ALT levels start to decrease from the second year of life and liver histology shows features of mild hepatitis. The long term consequences of HCV infection in children are unknown, although it seems likely that serious symptoms of infection may not occur for many years in vertically infected children. In addition to symptoms of chronic liver disease, they may also develop autoimmune symptoms. 6
7 SHOULD ANTENATAL SCREENING FOR HEPATITIS C VIRUS SHOULD BE MADE PART OF ROUTINE CARE IN THE UK? Children infected with HCV can be broadly classified into 3 categories, based on their outcome;(3) those who clear the virus (20%), generally occurring before 3 years of age, reflecting acute infection; those with chronic asymptomatic infection (50%), characterised by intermittent viraemia, normal ALT levels and rare hepatomegaly; and those with chronic active infection (30%), characterised by persistent viraemia, frequently abnormal ALT levels and hepatomegaly in some cases. In adults, spontaneous clearance of the virus is associated with the MHC class II alleles, DRB1*1101 and DQB1*0301, and they could also be implicated in children. Knowledge of the natural history of the condition concerned is vital for the institution of treatment and intervention. At present, regarding paediatric HCV infection, there are currently no interventions of proven safety and efficacy for the prevention of mother-tochild transmission of HCV (3) (see Table 1). Treatment of adult HCV infection comprises combination therapy of interferon α (IFN α) and ribavirin, and this is generally effective in decreasing viral load. It would, therefore, be ideal to use this treatment regime in pregnancy, as a decrease in viral load would decrease the risk of transmission. However, the use of IFN α is contraindicated in pregnancy due to potential deleterious effects on the fetus; IFN α is an anti-proliferative cytokine and therefore affects fetal growth. This feature also limits its use in the treatment of early paediatric HCV, and its use is not recommended in children less than 3 years old. In children older than 3 years, with compensated liver disease and no previous treatment with IFN α, combination therapy of IFN α and ribavirin is recommended. One of the main drawbacks of treatment in children is the requirement for injection 3 times a week. This could, potentially, be overcome by the use of pegylated interferon, which requires less frequent injections, in combination with ribavirin, as this regime in adults has proven to be effective. There are limited studies on the use of pegylated interferon in children; however, its use should be considered in those older than 5 years who are persistently viraemic and have persistently elevated ALT. It is important to note that the benefits of treating children earlier, as opposed to later in life, had not been sufficiently evaluated. If early treatment of exposed infants or children, confirmed as being vertically infected was found to be more beneficial than later treatment, this would strengthen the case for routine antenatal screening.(3) Regarding the actual screening process, a safe, valid and reliable screening test is available. The presence of HCV infection is determined by the detection of anti-hcv antibodies in a maternal blood sample, using enzyme immunoassays (EIA) or enzyme-linked immunosorbant assays (ELISA). If the result is positive, a second ELISA or confirmatory recombinant immunoblot assay (RIBA) is carried out on the same blood sample. If positive again, the woman is informed of the result, and another blood sample taken for a repeat ELISA test, to confirm the diagnosis. 7
8 THE WEST LONDON MEDICAL JOURNAL , 1 HCV prevalence (%) 1 st blood sample and ELISA test With 100% sensitivity:. of truly infected women (prevalence multiplied by the total number of pregnant women) (all identified by the screening test). of truly uninfected women (total number of pregnant women minus the number of truly infected women) With 96% specificity, 4 % of the truly uninfected women will be identified as positive by the screening test (false positive) Another ELISA or RIBA on the same sample for all that were positive (true positives+ false positives) With 100% sensitivity and 96% specificity: True positives (1 multiplied by the no. of truly infected women) False positives (0.04 multiplied by the no. of truly uninfected women identified as positive by the first ELISA test) Positive Predictive Value (PPV) (%) pregnant women per year in the UK tested by ELISA (approximately 8 per test) = = = nd blood sample and ELISA test Total number of women undergoing a 2 nd sample With 100% sensitivity and 96% specificity: True positives False positives Table 2: The effect of sensitivity and specificity in determining the presence or absence of infection, according to the prevalence of infection. The table considers the upper, middle and lower limits of estimated prevalence in the UK, to show how prevalence affects the proportion of cases correctly and incorrectly identified; with a higher prevalence, there are fewer false positives. PPV= positive predictive value (i.e. the number of people identified as positive who truly are positive). te that this value decreases as the prevalence decreases. Modified from the Working party report on screening for Hepatitis C in the UK,
9 SHOULD ANTENATAL SCREENING FOR HEPATITIS C VIRUS SHOULD BE MADE PART OF ROUTINE CARE IN THE UK? The sensitivity and specificity of ELISA, specifically used in anti-hcv antibody assays in pregnant women, are estimated to be 100% and 96% respectively. Table 2 summarises the effects of sensitivity and specificity in determining the presence or absence of infection, according to the prevalence of infection. The cost of screening all the pregnant women in the UK (estimated to be a year) each year would be between and , when considering only the cost of the ELISA and not the personnel involved. Following a positive result, the woman is offered post-test counselling, advising her about the implications of HCV infection for her and her infant, and the subsequent management of the pregnancy. Pre-natal diagnosis to confirm potential fetal infection is not performed and there are no known interventions that can prevent transmission: considerable anxiety is therefore involved with a positive result during pregnancy, in both women with false positive results and women correctly identified. Therefore, before the introduction of a routine antenatal screening programme for HCV infection, several criteria must be met, and, at present, a large proportion of these are not. Whilst HCV infection is a major public health problem and can lead to serious sequelae such as cirrhosis and hepatocellular carcinoma, the natural history of paediatric HCV infection remains to be elucidated; children are generally asymptomatic in early life, but may go on to develop the sequelae mentioned above in their teen or adult years. In addition, there are no known interventions proven to reduce transmission from mother-to-infant, and once infection has occurred, treatment is not suitable for those less than 3 years of age. The benefits of early versus late treatment are also yet to be revealed, although children are thought to be ideal candidates for anti-hcv treatment, as they have milder disease, with absence of both cirrhosis and co-morbidity. Despite the fact that a safe and reliable screening test is available, and it is generally accepted by pregnant women, it is still associated with a certain proportion of women who will have false positive results.(5) This, combined with the fact that, even in those correctly identified, there is no intervention possible to decrease the risk of maternal-fetal transmission or opportunity for treatment of the mother during pregnancy, may result in a great deal of anxiety. It is important to note that the antenatal screening programme is aimed to decrease the risk of paediatric infection, but it may have indirect benefits for the mother, such as the new discovery of asymptomatic infection, allowing treatment and lifestyle modifications. In addition, the test can be performed on the same sample of blood taken for the screening of Hepatitis B, HIV, Rubella and Syphilis, therefore causing no extra inconvenience to the mother. Table 3 provides a summary of the current situation. At present, much research is being carried out to try and satisfy the criteria. The work carried out by large, multicentre prospective studies, such as those within the European Paediatric HCV Network, as well as the data collected by the National HCV Register in the UK, will be of great benefit. 9
10 THE WEST LONDON MEDICAL JOURNAL , 1 Research still needs to be carried out to clarify the natural history of vertically acquired HCV. If effective interventions to decrease maternal-fetal transmission are unattainable, then the development of therapies for paediatric HCV will be particularly important. Criteria Evidence regarding HCV Satisfied in the context of antenatal HCV screening? The condition is an Global prevalence of 3%, with an important health antenatal prevalence of Yes problem approximately 1% in the UK The natural history is well understood Treatment or intervention of proven effectiveness is available A safe, valid and reliable screening test is available which is acceptable to those being tested. The risk of harm, both physical and psychological is less than the chance of benefit. The natural history of paediatric HCV infection is poorly classified The available treatment is contraindicated in pregnancy and there are no known interventions available The ELISA tests used have a high sensitivity (100%), satisfactory specificity (96%), but a low positive predictive value A positive result in pregnancy is associated with considerable anxiety. There is no benefit of diagnosis during pregnancy as there are no interventions Yes Table 3: To summarise whether HCV infection satisfies the criteria for the introduction of routine antenatal screening. (7). Hence, while, at present, it is not possible to routinely screen for HCV in pregnant women, and it is not advisable to just screen at-risk individuals (due to the absence of, or denial of, risk factors by many), it is important to address the fact that there are no national guidelines. Routine antenatal screening takes place in some centres in the UK, selective screening in others and some do not offer either. Therefore, in order to make practical use of the knowledge and data available, it is vital to develop guidelines for the management of women infected with, or at high risk of being infected with, HCV. 10
11 SHOULD ANTENATAL SCREENING FOR HEPATITIS C VIRUS SHOULD BE MADE PART OF ROUTINE CARE IN THE UK? To conclude, it is my point of view that, once areas of uncertainty have been clarified via research, routine antenatal screening of HCV should be introduced in the UK, as it has the potential to benefit both mother and child. REFERENCES National Screening Committee, Working party report on screening for Hepatitis C in the UK, January Pembrey L, Newell ML, Peckham C; Is there are case for Hepatitis C infection screening in the antenatal period?; Journal of Medical Screening; 2003; 10; 4; Syriopoulou V et al; Mother to child transmission of hepatitis C virus: rate of infection and risk factors; Scandinavian Journal of Infectious Disease; 2005; 37; 5; Ciommo VD, Russo P, Ravà L, Caprino L; Interferon α in the treatment of chronic hepatitis C in children: a metanalysis; Journal of Viral Hepatitis; 2005; 10; Ward C, Tudor-Williams G, Cotzias T, Hargreaves S, Regan L, Foster GR; Prevalence of hepatitis C among pregnant women attending an inner London obstetric department: uptake and accessibility of named antenatal testing; Gut; 2000; 47; Pembrey L, Newell ML, Tovo PA, EPHN Collaborators; The management of HCV infected pregnant women and their children; European Paediatric HCV Network; Journal of Hepatology; 2005; 43; Mok J, Pembrey L, Tovo PA, Newell ML, for the European Paediatric HCV Network; When does mother to child transmission of hepatitis C virus occur?; Archives of Disease in Childhood Neonatal and Fetal Edition; 2005; 90; Resti et al; Clinical features and progression of perinatally acquired Hepatitis C virus infection; Journal of Medical Virology; 2003; 70; European Paediatric HCV Network; Three broad modalities in the natural history of vertically acquired hepatitis C virus infection; Clinical Infectious Disease; 2005; 41;
Commonly Asked Questions About Chronic Hepatitis C
Commonly Asked Questions About Chronic Hepatitis C From the American College of Gastroenterology 1. How common is the hepatitis C virus? The hepatitis C virus is the most common cause of chronic viral
More informationPerinatal Transmission of Hepatitis C Virus
Perinatal Transmission of Hepatitis C Virus Vienna, 1 June 2017 VHPB MEETING Giuseppe Indolfi Meyer Children s University Hospital of Florence Perinatal Transmission of Hepatitis C Virus Outline definition
More informationViral Hepatitis Diagnosis and Management
Viral Hepatitis Diagnosis and Management CLINICAL BACKGROUND Viral hepatitis is a relatively common disease (25 per 100,000 individuals in the United States) caused by a diverse group of hepatotropic agents
More informationPERINATAL HEPATIDES AND HUMAN IMMUNODEFICIENCY VIRUS (HIV) Pamela Palasanthiran Staff Specialist, Paediatric Infectious Diseases
PERINATAL HEPATIDES AND HUMAN IMMUNODEFICIENCY VIRUS (HIV) Pamela Palasanthiran Staff Specialist, Paediatric Infectious Diseases Viruses in July (ViJ), 2004 Overview Epidemiology Perinatal transmission
More informationObstetric Complications in HIV-Infected Women. Jeanne S. Sheffield, MD Maternal-Fetal Medicine UT Southwestern Medical School
Obstetric Complications in HIV-Infected Women Jeanne S. Sheffield, MD Maternal-Fetal Medicine UT Southwestern Medical School Obstetric Complications and HIV Obstetric complications are not increased in
More informationHepatitis C. Core slides
Hepatitis C Core slides This material was prepared by the Viral Hepatitis Prevention Board The slides (or subsets) can be reproduced for educational use only, with reference to the original source and
More informationEpatite B: fertilità, gravidanza ed allattamento, aspetti clinici e terapeutici. Ivana Maida
Epatite B: fertilità, gravidanza ed allattamento, aspetti clinici e terapeutici Ivana Maida Positivity for HBsAg was found in 0.5% of tested women In the 70s and 80s, Italy was one of the European countries
More informationSummary of Key Points. WHO Position Paper on Vaccines against Hepatitis B, July 2017
Summary of Key Points WHO Position Paper on Vaccines against Hepatitis B, July 2017 1 Background l HBV is transmitted by exposure of mucosal membranes or non-intact skin to infected blood, saliva, semen
More informationHepatitis C Best Practice Guidelines For Local Health Departments
Hepatitis C Best Practice Guidelines For Local Health Departments LHDs are responsible for investigating and reporting all physician reported cases of acute hepatitis C (HCV). For clients known to have
More informationHEPATITIS C, ACUTE CRUDE DATA. Number of Cases 5 Annual Incidence a LA County 0.05 California b 0.10 United States b 0.68 Age at Diagnosis Mean 38
2016 Annual Morbidity Report HEPATITIS C, ACUTE a Rates calculated based on less than 19 cases or events are considered unreliable b Calculated from: CDC. Notice to Readers: Final 2016 Reports of Nationally
More informationRama Nada. - Malik
- 2 - Rama Nada - - Malik 1 P a g e We talked about HAV in the previous lecture, now we ll continue the remaining types.. Hepatitis E It s similar to virus that infect swine, so its most likely infect
More informationCITY & HACKNEY ELIC EAST LONDON INTEGRATED CARE MANAGEMENT OF CHRONIC HEPATITIS B IN PRIMARY CARE
CITY & HACKNEY ELIC EAST LONDON INTEGRATED CARE MANAGEMENT OF CHRONIC HEPATITIS B IN PRIMARY CARE Chronic Hepatitis B virus (HBV) is an important public health problem globally and a leading cause of liver
More informationEAST LONDON INTEGRATED CARE
CITY & HACKNEY ELIC EAST LONDON INTEGRATED CARE MANAGEMENT OF CHRONIC HEPATITIS B IN PRIMARY CARE Chronic Hepatitis B virus (HBV) is an important public health problem globally and a leading cause of liver
More informationLearning Objectives: Hepatitis Update. Primary Causes of Chronic Liver Disease in the U.S. Hepatitis Definition. Hepatitis Viruses.
Learning Objectives: Hepatitis Update ASCLS-Michigan March 31, 2016 Dr. Kathleen Hoag Upon attendance of this seminar and review of material provided, the attendees will be able to: 1. List hepatitis viruses
More informationHepatitis C Cure The Invisible Epidemic
Hepatitis C Cure The Invisible Epidemic Iris House 8 Th Annual Face of AIDS Summit Hadiyah Charles Hepatitis Advocacy Manager Harm Reduction Coalition Hepatitis C Basics A virus that can cause chronic
More informationViral hepatitis Blood Born hepatitis. Dr. MONA BADR Assistant Professor College of Medicine & KKUH
Viral hepatitis Blood Born hepatitis Dr. MONA BADR Assistant Professor College of Medicine & KKUH Outline Introduction to hepatitis Characteristics of viral hepatitis Mode of transmission Markers of hepatitis
More informationVIRAL HEPATITIS: SITUATION ANALYSIS AND PERSPECTIVES IN THE AFRICAN REGION. Report of the Secretariat. CONTENTS Paragraphs BACKGROUND...
8 April 2014 REGIONAL COMMITTEE FOR AFRICA ORIGINAL: ENGLISH PROGRAMME SUBCOMMITTEE Sixty-fourth session Brazzaville, Republic of Congo, 9 11 June 2014 Provisional agenda item 6 VIRAL HEPATITIS: SITUATION
More informationVIRAL HEPATITIS: SITUATION ANALYSIS AND PERSPECTIVES IN THE AFRICAN REGION. Report of the Secretariat. CONTENTS Paragraphs BACKGROUND...
5 November 2014 REGIONAL COMMITTEE FOR AFRICA ORIGINAL: ENGLISH Sixty-fourth session Cotonou, Republic of Benin, 3 7 November 2014 Provisional agenda item 11 VIRAL HEPATITIS: SITUATION ANALYSIS AND PERSPECTIVES
More informationHepatitis B Virus. Taylor Page PharmD Candidate 2019 February 1, 2019
Hepatitis B Virus Taylor Page PharmD Candidate 2019 February 1, 2019 Epidemiology 3218 cases of acute HBV reported in 2016 847,000 non-institutionalized persons living with chronic HBV in 2011-2012 Viral
More informationHEPATITIS B INFECTION and Pregnancy. Caesar Mensah Communicable Diseases & Infection Control Specialist, UK June 2011
HEPATITIS B INFECTION and Pregnancy Caesar Mensah Communicable Diseases & Infection Control Specialist, UK June 2011 HEPATITIS B 26/07/2011 What is Hepatitis B? It is inflammation (infection) of the liver
More informationCUMULATIVE PERINATAL HIV EXPOSURE, AUSTRALIA. Date
CUMULATIVE PERINATAL HIV EXPOSURE, AUSTRALIA 350 300 250 Number 200 150 100 50 0 1/01/1997 1/01/1998 1/01/1999 1/01/2000 31/12/2000 31/12/2001 31/12/2002 Date July 2004 Reported number of perinatally exposed
More informationCost-effectiveness of cesarean section delivery to prevent mother-to-child transmission of HIV-1 Halpern M T, Read J S, Ganoczy D A, Harris D R
Cost-effectiveness of cesarean section delivery to prevent mother-to-child transmission of HIV-1 Halpern M T, Read J S, Ganoczy D A, Harris D R Record Status This is a critical abstract of an economic
More informationHepatitis B. Data from the Travel Health Surveillance Section of the Health Protection Agency Communicable Disease Surveillance Centre
Hepatitis B Introduction Hepatitis B virus is one of the most prevalent viruses worldwide and is a major cause of chronic liver disease and hepatocellular carcinoma. It is a hepadnavirus, consisting of
More informationObstetrics and HIV An Update. Jennifer Van Horn MD University of Utah
Obstetrics and HIV An Update Jennifer Van Horn MD University of Utah Obstetrics and HIV Perinatal transmission Testing Antiretroviral therapy Antepartum management Intrapartum management Postpartum management
More informationHepatitis STARS Program. Geri Brown, M.D. Associate Professor Department of Internal Medicine October 4, 2003
Hepatitis 2003 STARS Program Geri Brown, M.D. Associate Professor Department of Internal Medicine October 4, 2003 Outline n Hepatitis A Epidemiology and screening Transmission n Hepatitis B Epidemiology
More informationin pregnancy Document Review History Version Review Date Reviewed By Approved By
GYNAECOLOGY/ ANTENATAL CARE WIRRAL WOMEN & CHILDREN S HOSPITAL Guideline No: Hepatitis B management in pregnancy VERSION 1 AMENDMENTS MADE: N/A DATE OF ISSUE: May 2012 DATE OF REVIEW: May 2015 REVIEW INTERVAL:
More informationHepatitis and pregnancy
Hepatitis and pregnancy Pierre-Jean Malè MD Training Course in Reproductive Health Research WHO Geneva 2008 26.02.2008 Liver disease and pregnancy: three possible etiologic relationship the patient has
More informationAppendix 1: summary of the modified GRADE system (grades 1A 2D)
Appendix 1: summary of the modified GRADE system (grades 1A 2D) 1A 1B 1C 1D 2A 2B 2C 2D Strong recommendation High-quality evidence Benefits clearly outweigh risk and burdens, or vice versa Consistent
More informationStudy population The patient population comprised HIV-positive pregnant women whose HIV status was known.
Prevention of mother-to-child transmission of HIV-1 infection: alternative strategies and their cost-effectiveness Ratcliffe J, Ades A E, Gibb D, Sculpher M J, Briggs A H Record Status This is a critical
More informationViral Hepatitis. Dr Melissa Haines Gastroenterologist Waikato Hospital
Viral Hepatitis Dr Melissa Haines Gastroenterologist Waikato Hospital Viral Hepatitis HAV HBV HCV HDV HEV Other viral: CMV, EBV, HSV Unknown Hepatitis A Hepatitis A Transmitted via the faecal-oral route
More informationLiver and pregnancy part 2 : pregnancy in patient with underlying liver disease
Liver and pregnancy part 2 : pregnancy in patient with underlying liver disease Ahmad Shavakhi.MD Associate professor Isfahan university of medical sciences Pregnancy in cirrhosis Pregnancy is a rare event
More informationChapter 2 Hepatitis B Overview
Chapter 2 Hepatitis B Overview 23 24 This page intentionally left blank. HEPATITIS B OVERVIEW Hepatitis B Virus The hepatitis B virus (HBV) belongs to the Hepadnaviridae family and is known to cause both
More informationDr Laura Byrne. UCL Institute of Child Health, London
Dr Laura Byrne UCL Institute of Child Health, London RCOG, London Elimination of vertical transmission in the UK: what is left to do? Results of the NSHPC audit of perinatal HIV since 2006 Laura Byrne,
More informationThe Alphabet Soup of Viral Hepatitis Testing
The Alphabet Soup of Viral Hepatitis Testing August 18, 2011 Patricia Slev, PhD, DABCC Medical Director, Serologic Hepatitis and Retrovirus Laboratory, ARUP Laboratories Assistant Professor of Pathology,
More informationManagement of Viral Infection during Pregnancy
Vaccination Management of Viral Infection during Pregnancy JMAJ 45(2): 69 74, 2002 Takashi KAWANA Professor of Obstetrics and Gynecology, Teikyo University Mizonokuchi Hospital Abstract: Viral infection
More informationComparison between ELISA and chemiluminescence immunoassay for the detection of Hepatitis C virus antibody
Original Research Article DOI: 10.18231/2394-5478.2017.0078 Comparison between ELISA and chemiluminescence immunoassay for the detection of Hepatitis C virus antibody Pampi Majumder 1, Anup Kumar Shetty
More informationNATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE Centre for Clinical Practice SCOPE Clinical guideline title: Hepatitis B (chronic): diagnosis and management of chronic hepatitis B in children, young
More information-HCV genome is about 9400 nucleotides long, it is ssrna and positive sense -the 10 viral proteins are first made as a large polyprotein -individual
2013: HCV Genome -HCV genome is about 9400 nucleotides long, it is ssrna and positive sense -the 10 viral proteins are first made as a large polyprotein -individual proteins are released from polyprotein
More informationThe ABCs of Viral Hepatitis Diagnosis. Ila Singh, M.D., Ph.D. P & S Viral Hepatitis. Hepatitis A, B, C, D, E and G viruses
The ABCs of Viral Hepatitis Diagnosis Ila Singh, M.D., Ph.D. P & S 14-453 is132@columbia.edu Viral Hepatitis Hepatotropic viruses Hepatitis A, B, C, D, E and G viruses Generalized infection plus infection
More informationMicropathology Ltd. University of Warwick Science Park, Venture Centre, Sir William Lyons Road, Coventry CV4 7EZ
www.micropathology.com info@micropathology.com Micropathology Ltd Tel 24hrs: +44 (0) 24-76 323222 Fax / Ans: +44 (0) 24-76 - 323333 University of Warwick Science Park, Venture Centre, Sir William Lyons
More informationConfirmed (Laboratory Tests) Serum positive for IgM anti-hbc or, hepatitis B surface antigen (HbsAg).
Hepatitis B Hepatitis B is a liver disease that results from infection with the Hepatitis B virus. It can range in severity from a mild illness lasting a few weeks to a serious, lifelong illness. Hepatitis
More informationC 肝職業暴露後之處置 衛福部疾病管制署 中區傳染病防治醫療網 王任賢指揮官
C 肝職業暴露後之處置 衛福部疾病管制署 中區傳染病防治醫療網 王任賢指揮官 HCV:Structure and Classification Unclassified virus, Member of the flavivirus family (other members yellow fever and dengue) Enveloped single stranded RNA virus Humans
More informationLabor & Delivery Management for Women Living with HIV. Pooja Mittal, DO Lisa Rahangdale, MD
Labor & Delivery Management for Women Living with HIV Pooja Mittal, DO Lisa Rahangdale, MD Statistics for Perinatally Acquired HIV Timing of Perinatal HIV Transmission Most transmission occurs close to
More informationViral Hepatitis. Background
Viral Hepatitis Background Hepatitis or inflammation of the liver can be caused by infectious and noninfectious problems. Infectious etiologies include viruses, bacteria, fungi and parasites. Noninfectious
More informationSIXTY-SECOND WORLD HEALTH ASSEMBLY A62/22 Provisional agenda item April Viral hepatitis. Report by the Secretariat
SIXTY-SECOND WORLD HEALTH ASSEMBLY A62/22 Provisional agenda item 12.17 16 April 2009 Viral hepatitis Report by the Secretariat THE DISEASES AND BURDEN 1. The group of viruses that cause acute and/or chronic
More informationA summary of guidance related to viral rash in pregnancy
A summary of guidance related to viral rash in pregnancy Wednesday 12 th July 2017 Dr Rukhsana Hussain Introduction Viral exanthema can cause rash in pregnant women and should be considered even in countries
More informationObjectives. Types of HIV Tests. Age Appropriateness of Tests. Breastfeeding and HIV Testing. Why are there different tests for different ages?
Objectives At the end of the lesson participants will be able to: Identify the types of HIV tests available in Botswana State who should be tested Identify which tests are used for infants and children
More informationHCV in the Latino Community -Epidemiology, Natural History, Risk Factors, Screening and Diagnosis
HCV in the Latino Community -Epidemiology, Natural History, Risk Factors, Screening and Diagnosis Wari Allison MD, PhD Assistant Professor/Research Dept. of Medicine/Infectious Disease Medical Director
More informationOutline. Aim with PMTCT. How are children transmitted. Prevention of mother-to-child transmission of HIV. How does HIV transmit to children?
Prevention of mother-to-child transmission of HIV Outline AimofPMTCT How HIV is transmitted to children Epidemiology of HIV in children How to reduce HIV transmission to children Guidelines Lars T. Fadnes
More informationChronic Hepatitis C. Risk Factors
Chronic Hepatitis C The hepatitis C virus is one of the most important causes of chronic liver disease in the United States. Almost 4 million Americans or 1.8 percent of the U.S. population have an antibody
More informationSandi Mitchell Nurse Educator Clinical Prevention Services BCCDC
Sandi Mitchell Nurse Educator Clinical Prevention Services BCCDC sandi.mitchell@bccdc.ca Hepatitis A, B and C Testing Transmission Treatment What Is Hepatitis? Hepatitis means inflammation of the liver
More informationHepatitis C: Let s Talk About It. Causes of Hepatitis
Hepatitis C: Let s Talk About It Susan Thompson, RN, MPH Technical Assistance and Training Program NC Communicable Disease Branch July 2012 Causes of Hepatitis any swelling, inflammation, or irritation
More informationUses and Misuses of Viral Hepatitis Testing. Origins of Liver Science
Uses and Misuses of Viral Hepatitis Testing Richard S Lang, MD, MPH, FACP Chairman, Preventive Medicine Vice-Chair, Wellness Institute Raul J Seballos, MD, FACP Vice-Chair, Preventive Medicine Wellness
More informationTHIS ACTIVITY HAS EXPIRED. CME CREDIT IS NO LONGER AVAILABLE
THIS ACTIVITY HAS EXPIRED. CME CREDIT IS NO LONGER AVAILABLE The following content is provided for informational purposes only. Diagnosing and Managing Hepatitis C Sandy Van Sant MPH, APN Hepatitis C virus
More informationHPI (2006) Question: Douglas T. Dieterich, MD. What is the risk of mother-to-child transmission in HCV for this woman?
Case Presentation Douglas T. Dieterich, MD Professor of Medicine Mount Sinai School of Medicine HPI (2006) Slide #2 HPI: 30 yo white woman, G0P0. HCV+. PMH & FH: H/o multiple HCV treatments in the past.
More informationWHAT S NEW IN THE 2015 PERINATAL HIV GUIDELINES?
WHAT S NEW IN THE 2015 PERINATAL HIV GUIDELINES? Today s Webinar will be starting soon For the audio portion of this meeting: Dial 1-855-702-5382 Enter participant code 596-825-4701# Guidelines for online
More informationHIV SCREENING WORKSHOP Exercise
HIV SCREENING WORKSHOP Exercise INTRODUCTION: Since its first discovery in 1981, AIDS became a pandemic. Worldwide, actually over 30 million people are living with HIV (i.e., are infected by the human
More informationViral Hepatitis - Historical Perspective
Viral Hepatitis - Historical Perspective Infectious A E Enterically transmitted Viral hepatitis NANB Serum B D F, G,? other C Parenterally transmitted Before the discovery of hepatitis A virus (HAV) and
More informationThe management of patients positive to hepatitis C virus antibody in Malta
The management of patients positive to hepatitis C virus antibody in Malta Anthea Brincat, Neville Azzopardi, Maria Deguara, Kelly Mifsud Taliana, Marilyn Rogers, James Pocock Abstract Hepatitis C virus
More information2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process
Quality ID #400 (NQF 3059): One-Time Screening for Hepatitis C Virus (HCV) for Patients at Risk National Quality Strategy Domain: Effective Clinical Care 2018 OPTIONS F INDIVIDUAL MEASURES: REGISTRY ONLY
More informationChronic Hepatitis B Infection
Chronic Hepatitis B Infection Mohssen Nassiri Toosi, MD Imam Khomeinin Hospital Tehran University of Medical Sciences Chronic Hepatitis B Infection Virus : HBs Ag Positive Host Liver Health Chronic Hepatitis
More informationAPEC Guidelines Immunizations
Pregnancy provides an excellent opportunity to enhance a woman s protection against disease and to provide protection to the neonate during the first 3 to 6 months of life. Women of childbearing age should
More informationRegister for notification of guideline updates at
Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-1-Infected Women for Maternal Health and Interventions to Reduce Perinatal HIV Transmission in the United States Visit the AIDSinfo website
More informationViral hepatitis. Supervised by: Dr.Gaith. presented by: Shaima a & Anas & Ala a
Viral hepatitis Supervised by: Dr.Gaith presented by: Shaima a & Anas & Ala a Etiology Common: Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E Less common: Cytomegalovirus EBV Rare: Herpes
More informationObjectives. Outline. Section 1: Interaction between HIV and pregnancy. Effects of HIV on Pregnancy. Section 2: Mother-to-Child-Transmission (MTCT)
Objectives Prevention of Mother-to-Child Transmission (PMTCT) Teen Club Community Partners Training Programme By the end of the session participants will be able to: 1. Identify factors affecting the transmission
More informationPrevention of Mother to Child Transmission of HIV: Our Experience in South India
pg 62-66 Original Article Prevention of Mother to Child Transmission of HIV: Our Experience in South India Karthekeyani Vijaya 1, Alexander Glory 2, Solomon Eileen 3, Rao Sarita 4, Rao P.S.S.Sunder 5 1
More informationViral Hepatitis in Reproductive Health
Viral Hepatitis in Reproductive Health Training Course in Sexual and Reproductive Health Research Geneva 2010 Dr José M Bengoa Dr Pierre Jean Malè Consultants Division of Gastroenterology and Hepatology
More informationHorizon Scanning Centre November Faldaprevir with BI for chronic hepatitis C infection, genotype 1 SUMMARY NIHR HSC ID: 7688
Horizon Scanning Centre November 2012 Faldaprevir with BI 207127 for chronic hepatitis C infection, genotype 1 SUMMARY NIHR HSC ID: 7688 This briefing is based on information available at the time of research
More informationHepatitis C January 26, 2018
Hepatitis C January 26, 2018 Case Investigation Guidelines Contents A. Purpose...2 B. Case Definitions...2 a. Acute Hepatitis C (2016...2 b. Chronic Hepatitis C (2016)...3 c. Perinatal Hepatitis C (2017
More informationGENITAL HERPES. 81.1% of HSV-2 infections are asymptomatic or unrecognized. Figure 14 HSV-2 seroprevalence among persons aged years by sex.
GENITAL HERPES Genital herpes is a chronic, lifelong, sexually transmitted disease caused by herpes simplex virus type 1 (HSV-1) and type 2 (HSV-2). HSV-1 typically causes small, painful, fluid-filled,
More informationkeyword: hepatitis Hepatitis
www.bpac.org.nz keyword: hepatitis Hepatitis Key reviewers: Dr Susan Taylor, Microbiologist, Diagnostic Medlab, Auckland Dr Tim Blackmore, Infectious Diseases Physician and Microbiologist, Wellington Hospital,
More informationNational Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention Increased Hepatitis C Virus (HCV) Detection in Women of Childbearing Age and Potential Risk for Vertical Transmission - United States
More informationHepatitis B Positive: Care of Mother Policy
Document ID: MATY031 Version: 1.0 Facilitated by: Jo McMullan, CMM Issue Date: July 2012 Approved by: Maternity Quality Committee Review date: October 2016 Hepatitis B Positive: Care of Mother Policy Purpose
More informationDr David Rowbotham NHS. The Leeds Teaching Hospitals. NHS Trust
Dr David Rowbotham The Leeds Teaching Hospitals NHS Trust NHS Nurses Update June 2010 Chronic Hepatitis HBV / HCV David Rowbotham Clinical Director & Consultant Gastroenterologist Dept of Gastroenterology
More informationNHS public health functions agreement Service specification No.1 Neonatal hepatitis B immunisation programme
NHS public health functions agreement 2017-18 Service specification No.1 Neonatal hepatitis B immunisation programme NHS public health functions agreement 2017-18 Service specification No.1Neonatal hepatitis
More informationAuthor s job title Screening Midwife Consultant Medical Microbiologist Directorate Women and Children
Document Control Title Author Author s job title Screening Midwife Consultant Medical Microbiologist Directorate Women and Children Department Antenatal Clinic Version Date Issued Status Comment / Changes
More informationTaken From VBA s Adjudication Procedure Manual Section on Hepatitis
Taken From VBA s Adjudication Procedure Manual Section on Hepatitis M21-1, Part III, Subpart iv, 4.I.2 Updated January 11, 2017 2. Hepatitis and Other Liver Disabilities Introduction Change Date January
More informationMichigan Guidelines: HIV, Syphilis, HBV in Pregnancy
Michigan Guidelines: HIV, Syphilis, HBV in Pregnancy Presenter: Theodore B. Jones, MD Maternal Fetal Medicine Wayne State University School of Medicine Beaumont Dearborn Hospital HIV, Syphilis, HBV in
More informationpatients with blood borne viruses Controlled Document Number: Version Number: 4 Controlled Document Sponsor: Controlled Document Lead:
CONTROLLED DOCUMENT Procedure for the management of patients with blood borne viruses CATEGORY: CLASSIFICATION: PURPOSE Controlled Document Number: Version Number: 4 Controlled Document Sponsor: Controlled
More informationHepatitis C in Australia:
Hepatitis C in Australia: Epidemiology and Clinical Presentation (and a bit of virology ) A/Prof Mark Douglas Hepatitis C - Distribution Te and Jensen 2010 Clin Liver Dis Hepatitis C Epidemiology Estimated
More informationCongenital CMV infection. Infectious and Tropical Pediatric Division Department of Child Health Medical Faculty, University of Sumatera Utara
Congenital CMV infection Infectious and Tropical Pediatric Division Department of Child Health Medical Faculty, University of Sumatera Utara Congenital CMV infection Approximately 0.15 2% of live births
More informationHepatitis C Virus (HCV) & Infectious Disease 101 for Hubs & Spokes April 24, :00 pm 1:00 pm
Hepatitis C Virus (HCV) & Infectious Disease 101 for Hubs & Spokes April 24, 2018 12:00 pm 1:00 pm Presenters: Thomas E. Freese, PhD, Larissa Mooney, MD, & Rachel McLean, MPH, Chief, Office of Viral Hepatitis
More informationINTERPROFESSIONAL PROTOCOL - MUHC
INTERPROFESSIONAL PROTOCOL - MUHC Medication included No Medication included THIS IS NOT A MEDICAL ORDER Title: PREVENTION OF MATERNAL TO INFANT HIV INFECTION Intrapartum, Peripartum, and Postpartum Antiretroviral
More informationNATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE Centre for Clinical Practice SCOPE Clinical guideline title: Hepatitis B (chronic): diagnosis and management of chronic hepatitis B in children, young
More informationNew recommendations for immunocompromised patients
New recommendations for immunocompromised patients Hepatitis E Virus (HEV): Transmission, incidence and presentation Emerging evidence regarding HEV transmission from blood components and dietary consumption
More informationShould we treat hepatitis B positive pregnant women to prevent mother to child transmission?
Should we treat hepatitis B positive pregnant women to prevent mother to child transmission? Daniel Shouval Liver Unit Hadassah-Hebrew University Hospital Jerusalem, Israel VHPB Vienna June 1-2, 2017 Background
More informationOB Provider Guide to Alaska s Perinatal Hepatitis B Prevention Program
OB Provider Guide to Alaska s Perinatal Hepatitis B Prevention Program Dear Colleague, This letter is to introduce myself and explain the role I play with the Alaska Perinatal Hepatitis B Program. Alaska
More informationNHS public health functions agreement
NHS public health functions agreement 2016-17 Service specification No.1 Neonatal hepatitis B immunisation programme Classification: official NHS England INFORMATION READER BOX Directorate Medical Commissioning
More informationWomen are the fastest-growing group of persons with
Clinical Guidelines Prenatal Screening for HIV: A Review of the Evidence for the U.S. Preventive Services Task Force Roger Chou, MD; Ariel K. Smits, MD, MPH; Laurie Hoyt Huffman, MS; Rongwei Fu, PhD; and
More informationHepatitis B Positive: Care of Mother Policy
Document ID: MATY031 Version: 1.0 Facilitated by: Jo McMullan, CMM Last reviewed: October 2014 Approved by: Maternity Quality Committee Review date: October 2016 Hepatitis B Positive: Care of Mother Policy
More informationA "State-of-the-Art" Conference Hepatitis C: A Meeting Ground for the Generalist and the Specialist
A "State-of-the-Art" Conference Hepatitis C: A Meeting Ground for the Generalist and the Specialist Information regarding pathogenesis and appropriate management of chronic hepatitis C continues to evolve.
More informationHealth Care Worker (Pregnant) - Infectious Diseases Risks and Exposure
1. Purpose The purpose of this guideline is to provide accurate information on the risks to pregnant Health Care Workers (HCWs) in the event of an exposure to a transmissible infectious disease at the
More informationHEPATITIS VIRUSES. Other causes (not exclusively hepatitis v.)also called sporadic hepatitis: HEPATITIS A(infectious hepatitis)
Dept.of Microbiology/Virology Assist.prof. Shatha F. Abdullah HEPATITIS VIRUSES Medically important hepatitis v. (liver)are: 1.HAV 2.HBV 3.HCV 4.HDV 5.HEV 6.HGV Other causes (not exclusively hepatitis
More informationHepatitis C Seroprevalence Among HIV-Infected Childbearing Women in New York State in 2006
DOI 10.1007/s10995-015-1853-4 Hepatitis C Seroprevalence Among HIV-Infected Childbearing Women in New York State in 2006 L. Ghazaryan 1 L. Smith 2 M. Parker 3 C. Flanigan 4 W. Pulver 2 T. Sullivan 5 A.
More informationVersion for the Silent Procedure 29 April Agenda item January Hepatitis
Version for the Silent Procedure 29 April 2014 134th session EB134.R18 Agenda item 10.5 25 January 2014 Hepatitis The Executive Board, Having considered the report on hepatitis, 1 RECOMMENDS to the Sixty-seventh
More informationThese precautions should be followed for 7 days after symptom onset or 24 hours after resolution of symptoms, whichever is longer.
1 of 5 11/15/2009 10:34 AM H1N1 Flu November 10, 2009 4:30 PM ET This interim guidance has been updated to replace previously posted guidance entitled Considerations Regarding Novel H1N1 Flu Virus in Obstetric
More informationViral Hepatitis Update: Screening, Vaccination, and Treatment
Viral Hepatitis Update: Screening, Vaccination, and Treatment Alaska Maternal Child Health & Immunization Conference September 28, 2016 Prabhu Gounder, MD, MPH, FACP Medical officer, CDC Arctic Investigations
More informationtreatment during pregnancy and breastfeeding
treatment during pregnancy and breastfeeding Topics covered Introduction. Preventing parent-to-child transmission. AZT as a single therapy. Treatment begun late in pregnancy. Nevirapine for mothers and
More informationCarrier state and chronic infection state. At-risk populations
John T. Stutts, MD, MPH University of Louisville School of Medicine Department of Pediatrics Division of Pediatric Gastroenterology, Hepatology and Nutrition Carrier state and chronic infection state -
More information